Your doctor will likely suspect factor V Leiden if you've had one or more episodes of thrombosis or pregnancy loss or if you have a strong family history of thrombotic disease. Your doctor can confirm that you have factor V Leiden with a blood test. Two types of tests can be done:
- Activated protein C resistance test. Your blood sample may be tested to determine whether your blood is resistant to activated protein C, one of the anti-clotting proteins that help control factor V. This is known as an activated protein C (APC) resistance assay. If your blood is resistant to activated protein C, you likely have a mutation in the factor V gene.
-
Genetic test. A genetic test is done to determine whether you have a factor V gene mutation. It may also be used to confirm the results of the APC resistance test or to determine whether you've inherited one or two copies of the gene mutation.
If you're taking blood-thinning medications (anticoagulants), you may have only the genetic test. Anticoagulants interfere with the activated protein C resistance test.
Testing babies before or soon after birth isn't recommended. Children who don't have symptoms of clotting problems also don't need screening. Blood clots are rare, even in children with factor V Leiden. Testing isn't recommended until adulthood.
When your child is an adult, he or she will be better able to fully understand the risks and benefits associated with genetic testing. Chances are good that your child may never have any signs or symptoms related to factor V Leiden.
July 14, 2015
- Bauer KA. Management of inherited thrombophilia. http://www.uptodate.com/home. Accessed June 6, 2015.
- Cronenwett JL, et al. Hypercoagulable states. In: Rutherford's Vascular Surgery. 8th ed. Philadelphia, Pa: Saunders Elsevier; 2014. http://www.clinicalkey.com. Accessed June 6, 2015.
- Kujovich JL. Factor V Leiden thrombophilia. Genetics in Medicine. 2011;13:1.
- AskMayoExpert. Factor V Leiden (FVL). Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
- Bauer KA. Factor V Leiden and activated protein C resistance: Clinical manifestations and diagnosis. http://www.uptodate.com/home. Accessed June 6, 2015.
- Deep vein thrombosis. Merck Manual Professional Version. http://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt. Accessed June 6, 2015.
- Superficial venous thromobosis. Merck Manual Professional Version. http://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/superficial-venous-thrombosis. Accessed June 6, 2015.
- What is pulmonary embolism? National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/pe/signs. Accessed June 6, 2015.
- Bauer KA. Screening for inherited thrombophilia in asymptomatic individuals. http://www.uptodate.com/home. Accessed June 6, 2015.
- Lockwood CJ, et al. Inherited thrombophilias in pregnancy. http://www.uptodate.com/home. Accessed June 6, 2015.
- Cronenwett JL, et al. Acute deep venous thrombosis. In: Rutherford's Vascular Surgery. 8th ed. Philadelphia, Pa: Saunders Elsevier; 2014. http://www.clinicalkey.com. Accessed June 6, 2015.
- Bauer KA, et al. Evaluating patients with established venous thromboembolism for acquired and inherited risk factors. http://www.uptodate.com/home. Accessed June 6, 2015.
- Raffini L. Screening for inherited thrombophilia in children. http://www.uptodate.com/home. Accessed June 6, 2015.
- Pulmonary embolism. Merck Manual Professional Version. http://www.merckmanuals.com/professional/pulmonary-disorders/pulmonary-embolism-pe/pulmonary-embolism-pe. Accessed June 6, 2015.
- Your guide to preventing and treating blood clots. Agency for Healthcare Research & Quality. http://www.ahrq.gov/patients-consumers/prevention/disease/bloodclots.html#preventing. Accessed June 6, 2015.
- Litin SC (expert opinion). Mayo Clinic, Rochester, Minn. June 16, 2015.
- Gómez-Outes A, et al. Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in patients with nonvalvular atrial fibrillation: A systematic review and meta-analysis of subgroups. Thrombosis. 013; 2013: 640723. http://www.hindawi.com/journals/thrombosis/2013/640723/. Accessed June 16, 2015.
.